Spanred Formulation Private Limited

Spanred Formulation Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U74999GJ2016PTC093266 Incorporated 08 August 2016 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2019
₹45.67 Lakh
▼ 29% YoY
Net profit · FY 2019
₹46,466
Net margin 1%
EBITDA · FY 2019
₹1.03 Lakh
EBITDA margin 2.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹7.5 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings

About Spanred Formulation Private Limited

Data last updated:

Spanred Formulation Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC093266. Its GSTIN is 24AAXCS5006Q1ZM (Gujarat).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanal Rakeshbhai Shah and Rakeshkumar Jayantilal Shah.

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Plot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760.

As per the financials filed for FY 2019, the company reported a revenue of ₹45.67 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹46,466 (net margin 1%) and EBITDA of ₹1.03 Lakh (EBITDA margin 2.3%).

As per MCA filings, the company has open charges of ₹7.5 Lakh on record.

Spanred Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0046789). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999GJ2016PTC093266
Registration Number 093266
Incorporation Date 08 August 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0046789

Recognitions & Rankings of Spanred Formulation

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-24-0046789

Contact details

Spanred Formulation Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Spanred Formulation Private Limited, buy the company report.

Comprehensive company report
Spanred Formulation Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Spanred Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Spanred Formulation Private Limited, buy the company report.

Financials of Spanred Formulation Private Limited

FY 2019 filings available

Spanred Formulation Private Limited reported revenue of ₹45.67 Lakh (down 29% YoY) for FY 2019.

Revenue · FY 2019
₹45.67 Lakh ▼ 29%
Net profit · FY 2019
₹46,466 margin 1%
EBITDA · FY 2019
₹1.03 Lakh margin 2.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 29%
EBITDA CAGR growth
1 year
▼ 34%

Revenue fell 29% in the latest year. EBITDA fell 34% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations₹45.67 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.03 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹46,466
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin2.3%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Spanred Formulation Private Limited, buy the company report.

Board of directors of Spanred Formulation Private Limited

Spanred Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kanal Rakeshbhai ShahDirector07 Mar 20188 Years 7 MonthsCurrent
Rakeshkumar Jayantilal ShahDirector08 Aug 201610 Years 2 MonthsCurrent

Peer comparison

Spanred Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Proothvi Biotech Private Limited₹45.77 Lakh (FY 2025)118.0%Nagpur, Maharashtra, India
Ctga Biopharma India Private Limited₹45.77 Lakh (FY 2025)-11.0%Hyderabad, Telangana, India
Curizo Meditech Private Limited₹45.73 Lakh (FY 2023)64.0%Surat, Gujarat, India
Folis Allied Core Private Limited₹45.7 Lakh (FY 2020)-31.0%Secendrabad, Telangana, India
Espiritos India Private Limited₹45.69 Lakh (FY 2024)-19.0%Navi Mumbai, Maharashtra, India
Spanred Formulation Private Limitedthis company₹45.67 Lakh (FY 2019)₹46,4661%-29.0%Vadodara, Gujarat, India
Rajmeen Aromas Private Limited₹45.55 Lakh (FY 2025)133.0%Vadodara, Gujarat, India
Lograns Pharma Private Limited₹45.53 Lakh (FY 2025)14.0%Hyderabad, Telangana, India
Flycatcher Pharmaceuticals Private Limited₹45.52 Lakh (FY 2019)154.0%Kattupakkam, Tamil Nadu, India
Stealth Oxygen Company Private Limited₹45.5 Lakh (FY 2022)Jammu and Kashmir, India
Kairali Paints Private Limited₹45.48 Lakh (FY 2015)-7.0%Ernakulam, Kerala, India

To see the full peer comparison of Spanred Formulation Private Limited, buy the company report.

Auditor

Spanred Formulation Private Limited is audited by MINESH M SHAH & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
MINESH M SHAH & COFY 2019116492W

Shareholding

The shareholding of Spanred Formulation Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Spanred Formulation Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.08 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Jul 2018100194068State Bank of India₹7.5 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Spanred Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Spanred Formulation has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAXCS5006Q1ZMGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Spanred Formulation Private Limited, buy the company report.

Recent activity

Spanred Formulation Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Ashish Hasmukhbhai Patel ceased to be Director on 10 Mar 2018.

AGM
Spanred Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Spanred Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad.
Charges
A charge with State Bank Of India amounted to Rs. 7.50 Lakh with Charge ID 100194068 was registered on 05 Jul 2018.
Ceased
Ashish Hasmukhbhai Patel ceased to be Director.
Ceased
Ashishkumar Bhalchandra Dave ceased to be Director.
Appointed
Kanal Rakeshbhai Shah was appointed as Director.
Appointed
Rakeshkumar Jayantilal Shah was appointed as Director.
Incorporation
08 Aug 2016
Spanred Formulation Private Limited was registered on 08 Aug 2016 with Roc Ahmedabad & aged 10 years 2 months as per MCA records.

Frequently asked questions

Spanred Formulation is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC093266.

Spanred Formulation has 2 current directors:

The latest financial statements of Spanred Formulation on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Spanred Formulation is 24AAXCS5006Q1ZM, registered in Gujarat.

The CIN (Corporate Identification Number) of Spanred Formulation is U74999GJ2016PTC093266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spanred Formulation was incorporated on 08 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Spanred Formulation by revenue are Proothvi Biotech Private Limited, Ctga Biopharma India Private Limited, Curizo Meditech Private Limited, Folis Allied Core Private Limited, Espiritos India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ashish Hasmukhbhai Patel ceased to be Director on 10 Mar 2018. Ashishkumar Bhalchandra Dave ceased to be Director on 10 Mar 2018. Kanal Rakeshbhai Shah was appointed as Director on 07 Mar 2018. Spanred Formulation has 4 board changes on record in total.

Yes, Spanred Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0046789).

The registered office of Spanred Formulation is at Plot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760.

Spanred Formulation operates in the pharma industry, in the drug formulation and development segment.